K. Kroker

发表

Role of PDE9 in Cognition.

H. Rosenbrock, C. Dorner‐Ciossek, K. Kroker, 2017, Advances in neurobiology.

Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

H. Kestler, L. Lausser, Florian Schmid, 2017, Alzheimer's Research & Therapy.

Inhibition of PDE2A, but not PDE9A, modulates presynaptic short‐term plasticity measured by paired‐pulse facilitation in the CA1 region of the hippocampus

H. Rosenbrock, D. Fernández-Fernández, K. Kroker, 2015, Synapse.

Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP

H. Rosenbrock, G. Rast, C. Dorner‐Ciossek, 2012, Neuropharmacology.

Establishment and validation of hippocampal LTP for characterization of memory enhancing drugs as potential treatment of Alzheimer’s disease

K. Kroker, Katja S. Kroker, 2012 .

Differential effect of the mGlu5 receptor positive allosteric modulator ADX-47273 on early and late hippocampal LTP

H. Rosenbrock, G. Rast, K. Kroker, 2011, Neuropharmacology.

Age‐related synaptic dysfunction in Tg2576 mice starts as a failure in early long‐term potentiation which develops into a full abolishment of late long‐term potentiation

H. Rosenbrock, D. Fernández-Fernández, C. Dorner‐Ciossek, 2016, Journal of neuroscience research.

Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice

Georg Rast, Bastian Hengerer, T. Strassmaier, 2018, PloS one.

Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP.

H. Rosenbrock, G. Rast, K. Kroker, 2011, European journal of pharmacology.

Restoring long-term potentiation impaired by amyloid-beta oligomers: Comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists

H. Rosenbrock, L. Kussmaul, G. Rast, 2013, Brain Research Bulletin.

sAPPβ and sAPPα increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca2+ homeostasis and CREB1-signaling

Rosemary J. Jackson, H. Kestler, K. Föhr, 2018, Experimental Neurology.

Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

H. Kestler, L. Lausser, Florian Schmid, 2017, Alzheimer's Research & Therapy.

PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition

C. Mathis, J. Cassel, H. Rosenbrock, 2014, Neurobiology of Aging.

Globular and protofibrillar aβ aggregates impair neurotransmission by different mechanisms.

C. V. von Arnim, B. Hengerer, C. Schnack, 2013, Biochemistry.